We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FKWL icon
12676
Franklin Wireless
FKWL
$27M
$49K ﹤0.01%
12,360
-8,199
-40% -$33.7K
OLMA icon
12677
PUT
Olema Pharmaceuticals
OLMA
$1.05B
$49K ﹤0.01%
+11,600
New +$63.9K
REVB icon
12678
Revelation Biosciences
REVB
$4.46M
0
XOSWW
12679
Xos Inc Warrants
XOSWW
$12.2K
$49K ﹤0.01%
115,000
-181,326
-61% -$59.5K
ZVIA icon
12680
Zevia
ZVIA
$111M
$49K ﹤0.01%
+10,654
New +$74.2K
DXYN
12681
CALL
DELISTED
Dixie Group Inc
DXYN
$49K ﹤0.01%
15,700
+5,300
+51% +$22.1K
MVLAW
12682
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$49K ﹤0.01%
134,312
ZYNE
12683
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$49K ﹤0.01%
24,000
-39,100
-62% -$93K
ARDS
12684
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$49K ﹤0.01%
28,360
+13,626
+92% +$25.8K
SEAC
12685
CALL
DELISTED
Seachange International Inc
SEAC
$49K ﹤0.01%
2,170
-420
-16% -$10.6K
LHDX
12686
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$49K ﹤0.01%
13,700
-7,400
-35% -$36.3K
MIT.WS
12687
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$49K ﹤0.01%
149,121
-1
-0%
PIPP.WS
12688
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
$49K ﹤0.01%
102,773
-120,083
-54% -$74.4K
SPI
12689
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$49K ﹤0.01%
17,100
-21,800
-56% -$69.7K
ALGS icon
12690
Aligos Therapeutics
ALGS
$34.9M
$48K ﹤0.01%
893
+252
+39% +$20.2K
BBAR icon
12691
CALL
BBVA Argentina
BBAR
$3.49B
$48K ﹤0.01%
13,500
-3,600
-21% -$11.7K
FOA icon
12692
PUT
Finance of America Companies
FOA
$198M
$48K ﹤0.01%
1,580
-1,020
-39% -$35.5K
FTFT icon
12693
CALL
Future FinTech Group
FTFT
$1.47M
$48K ﹤0.01%
79
+34
+76% +$23K
JSPR icon
12694
PUT
Jasper Therapeutics
JSPR
$23.6M
$48K ﹤0.01%
1,360
-1,970
-59% -$88.8K
LODE icon
12695
Comstock
LODE
$245M
$48K ﹤0.01%
2,859
-11,213
-80% -$173K
RKDA icon
12696
Arcadia Biosciences
RKDA
$1.52M
$48K ﹤0.01%
851
-766
-47% -$36.5K
UNCY icon
12697
Unicycive Therapeutics
UNCY
$139M
$48K ﹤0.01%
+3,720
New +$54.5K
URG
12698
Ur-Energy
URG
$556M
$48K ﹤0.01%
29,882
-16,213
-35% -$22.9K
WATT icon
12699
PUT
Energous
WATT
$102M
$48K ﹤0.01%
67
-30
-31% -$20.8K
CNCE
12700
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$48K ﹤0.01%
14,300
-11,200
-44% -$35.5K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.